Skyview Clinical Research Division

Skyview’s Clinical Research Division is a physician owned and managed clinical research site committed to providing therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies.

Every member of the Skyview Clinical Research Division team is committed to making a distinctive contribution to the health and
well-being of people. That's the sense of purpose shared by every Skyview Clinical Research Division employee. Our mission is to support key advances in the discovery and development of new drugs, and the diagnosis and treatment of disease. Our continued success is built on a strong risk management foundation; we have the skills and the experience to deliver results that you can trust.

Our customers can count on Skyview Clinical Research Division to provide value-added services that increase the speed, precision and productivity of their efforts to bring much-needed drugs to market safely and efficiently.

About Clinical Trials
Every year, thousands of people help gather critical scientific data by participating in research studies involving a wide range of new and currently marketed medications.

A clinical trial is a research study in which volunteers receive investigational treatments under the supervision of a physician and other research professionals. These treatments are developed by pharmaceutical and biotechnology companies who select qualified physicians, also known as investigators, to conduct clinical trials to determine the benefits of investigational drugs.

Clinical trials are conducted to collect data regarding the safety and efficacy of new drug and device development. Drug and device testing begins with extensive laboratory research which can involve years of experiments in animals and human cells. If the initial laboratory research is successful, researches send the data to the Food and Drug Administration (FDA) for approval to continue research and testing in humans.

There are several steps and stages of approval in the human clinical trials process before a drug or device can be sold in the consumer market, if ever. Clinical trials are usually conducted in three phases (I, II, III). Only a small number of people participate in phase I trials while the later phases involve a larger number of volunteers. Each phase is considered a separate trial and, after completion of a phase, investigators are required to submit their data for approval from the FDA before continuing to the next phase.

For Potential Participants
Skyview is actively recruiting patients for clinical trials in several therapeutic areas.